New drug shows promise for motor neurone disease treatment

No­vo Nordisk’s Ry­bel­sus pill was long ex­pect­ed to be a hit out of the gate. The Dan­ish drug­mak­er cashed in a pri­or­i­ty re­view vouch­er in

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

Treating all household contacts of someone with tuberculosis (TB) helped prevent active TB disease across age groups in the real world, but the effectiveness was